Health
Vaccine Brand Is Tough Sell in Europe – Newser
Experts say comparisons of the products’ efficacy can be misleading

(Newser)
Many Europeans are desperate for a coronavirus vaccine. But not just any vaccine. As AstraZeneca shots are rolling out to European Union nations this month, joining the Pfizer and Moderna doses already available, some people are balking at being offered a vaccine that they perceive—fairly or not—as second-best. Poland began vaccinating teachers Friday with the AstraZeneca vaccine, the AP reports, and some had misgivings about being put in line for a vaccine they believe is less effective…
-
Business16 hours ago
Why is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours ago
Michael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News15 hours ago
‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News12 hours ago
Tips to improve engagement – Proctor